# Elevated Initial APRI Value Was Associated With SALD

> **NCT05999331** · — · UNKNOWN · sponsor: **Chinese Medical Association** · enrollment: 160 (estimated)

## Conditions studied

- Liver Dysfunction
- Sepsis-associated Liver Dysfunction

## Interventions

- **OTHER:** initial aspartate aminotransferase (AST) to platelet (PLT) ratio index

## Key facts

- **NCT ID:** NCT05999331
- **Lead sponsor:** Chinese Medical Association
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05999331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05999331, "Elevated Initial APRI Value Was Associated With SALD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05999331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*